GE HealthCare Technologies Inc. $GEHC Stake Lowered by Yousif Capital Management LLC

Yousif Capital Management LLC cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,938 shares of the company’s stock after selling 8,551 shares during the quarter. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $3,976,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the company. Wedge Capital Management L L P NC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth $26,859,000. Lineweaver Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at $592,000. Osaic Holdings Inc. boosted its holdings in GE HealthCare Technologies by 18.1% in the second quarter. Osaic Holdings Inc. now owns 224,869 shares of the company’s stock worth $16,674,000 after purchasing an additional 34,499 shares in the last quarter. National Bank of Canada FI boosted its holdings in GE HealthCare Technologies by 133.3% in the second quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after purchasing an additional 514,007 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in GE HealthCare Technologies by 4.2% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock worth $11,842,000 after buying an additional 6,479 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of analyst reports. Jefferies Financial Group boosted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Evercore ISI raised their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Citigroup boosted their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, Barclays initiated coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target on the stock. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $87.09.

GE HealthCare Technologies Stock Performance

GEHC opened at $83.29 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock’s 50 day moving average price is $78.55 and its two-hundred day moving average price is $75.73. The firm has a market capitalization of $37.94 billion, a P/E ratio of 17.21, a price-to-earnings-growth ratio of 3.48 and a beta of 1.10. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.